Historical record - last NADAC publication: 1/4/2017
Product Information
ACTOS 30 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $19.0212 per EA under NDC 64764030114. Its NADAC has been published 216 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the pioglitazone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764030114
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
1/4/2017
Active Ingredients
PIOGLITAZONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021073On Market Since
7/15/1999
Pharmacological Classes
Price Statistics
The NADAC for ACTOS 30 MG TABLET has been published 216 times since Nov 28, 2013, and over the history we have for it it has risen 66.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.0212 per EA |
|---|---|
| All-time high | $19.0212 (Jan 10, 2018) |
| All-time low | $11.4432 (Nov 28, 2013) |
| Median price | $16.8035 |
| Average price | $16.3532 |
| Largest weekly change | +9.9% (Jan 14, 2015) |
| Weeks tracked | 216 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACTOS 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACTOS 30 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $19.0212 per EA (NDC 64764030114), effective Jan 10, 2018.
How has the price of ACTOS 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACTOS 30 MG TABLET has risen 66.2%. It has been tracked across 216 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ACTOS 30 MG TABLET?
Since Nov 28, 2013, the NADAC for ACTOS 30 MG TABLET has ranged from a low of $11.4432 (Nov 28, 2013) to a high of $19.0212 (Jan 10, 2018), with a median of $16.8035 per EA.
Are there cheaper alternatives to ACTOS 30 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, ACTOS 30 MG TABLET, is $15.2899 per EA — about 20% below ACTOS 30 MG TABLET.
Who manufactures ACTOS 30 MG TABLET?
ACTOS 30 MG TABLET (NDC 64764030114) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification